Abstract
Introduction Brain fog (i.e., memory complaints and concentration difficulties) is frequently reported during the menopausal transition. There is lack of standardized scales available to measure brain fog across the menopause transition. This study aimed to evaluate the factor structure of the Everyday Memory Questionnaire-Revised (EMQ-R) and to determine the most commonly reported everyday cognitive symptoms in a menopausal population.
Methods 417 females, including 107 pre-menopausal, 149 peri-menopausal, and 161 early post-menopausal, met criteria and were included in the analyses. Memory and attention related symptoms were measured using the EMQ-R. Confirmatory factor analysis (CFA) was conducted to test the model fit of the bifactor structure (attentional and retrieval) of the EMQ-R in menopausal populations and evaluated by Cronbach’s alpha test. One way ANOVA and MANCOVA were used to investigate the group differences of individual items and two subscales.
Results CFA indicated that the bifactor model (retrieval and attentional) of the EMQ-R has a good fit in all three groups. A significant difference (with the highest mean score observed in peri-menopausal group) was identified in the retrieval subscale score (F=3.17, p=0.043) but not in the attentional subscale or total scores amongst the three groups. Items (1, 3, 5) related to daily information retrieval problems were significantly reported in the peri-menopausal group.
Discussion The EMQ-R serves as an instrument to measure memory and attention symptoms, referred to as ‘brain fog’ in menopause. Increased memory retrieval complaints reported by peri-menopausal group suggests a transition-related memory retrieval dysfunction during menopausal transition.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Monash University in the way of student scholarship (i.e., Monash Graduate Scholarship and Monash International Tuition Scholarship).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Monash University Human Research Ethics Committees gave ethical approval for this work (Ref. 2021-27653-66980).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
